Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in TaxesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Cash from Financing Activities (2022 - 2025)

Historic Cash from Financing Activities for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$99314.7.

  • InflaRx's Cash from Financing Activities rose 685.9% to -$99314.7 in Q3 2025 from the same period last year, while for Sep 2025 it was $28.9 million, marking a year-over-year increase of 702825.06%. This contributed to the annual value of $418265.3 for FY2024, which is 9926.63% down from last year.
  • As of Q3 2025, InflaRx's Cash from Financing Activities stood at -$99314.7, which was up 685.9% from -$112714.9 recorded in Q2 2025.
  • InflaRx's 5-year Cash from Financing Activities high stood at $57.9 million for Q2 2023, and its period low was -$115600.7 during Q2 2024.
  • In the last 4 years, InflaRx's Cash from Financing Activities had a median value of -$97324.1 in 2022 and averaged $5.9 million.
  • As far as peak fluctuations go, InflaRx's Cash from Financing Activities surged by 5956230.93% in 2023, and later plummeted by 38721.82% in 2024.
  • Quarter analysis of 4 years shows InflaRx's Cash from Financing Activities stood at $2.3 million in 2022, then crashed by 104.53% to -$102107.8 in 2023, then skyrocketed by 808.08% to $723002.0 in 2024, then crashed by 113.74% to -$99314.7 in 2025.
  • Its last three reported values are -$99314.7 in Q3 2025, -$112714.9 for Q2 2025, and $28.4 million during Q1 2025.